The expression and function of CD3 and CD5 in patients with primary sjögren's syndrome
Open Access
- 1 April 1989
- journal article
- research article
- Published by Wiley in Arthritis & Rheumatism
- Vol. 32 (4), 420-429
- https://doi.org/10.1002/anr.1780320411
Abstract
We studied the expression and function of 2 cell surface markers that induce T cell activation, CD3 and CD5, in 19 patients with primary Sjögren's syndrome (SS). The expression of CD3+ lymphocytes was normal, but CD3 function was moderately reduced, as measured by anti-CD5–induced T cell proliferation. Anti-CD3–induced stimulation of T cell help for Ig production and non–major histocompatibility complex–restricted (natural) killing were normal. In contrast, there was reduced expression and function of the CD5 molecule on peripheral blood lymphocytes of the SS patients. The ratio of CD5+ to CD3+ lymphocytes was 0.45 in SS patients compared with 0.85 in normal subjects, indicating that the CD3+ cells are relatively CD5-deficient in SS patients. Anti-CD5 monoclonal antibody did not augment suboptimal anti-CD3 stimulation of whole peripheral blood lymphocytes or of purified T lymphocytes from SS patients, which indicated impaired functioning of the CD5 molecule. A significant impairment in proliferation was found in response to phorbol myristate acetate and to ionomycin in combination, suggesting defective intracellular signaling. Findings from serial studies of individual patients suggested that normal or low expression of CD5 on T cells can be stable over periods as long as 2 years. However, in 2 patients who required systemic therapy, a correction of the CD5 lymphocyte abnormality occurred in association with clinical remission, which suggests the potential reversibility of this condition. Our findings suggest a possible defect in intracellular signaling in primary SS, related in part to the CD5 molecule, which may provide a molecular explanation for the T cell hyporesponsiveness that is characteristic of this disease.This publication has 44 references indexed in Scilit:
- Defective induction of T-cell help and natural killing following anti-CD3 stimulation of autoimmune lymphocytesJournal of Autoimmunity, 1988
- B cells expressing cd5 are increased in sjögren's syndromeArthritis & Rheumatism, 1988
- Human Lymphocytes Making Rheumatoid Factor and Antibody to ssDNA Belong to Leu-1 + B-Cell SubsetScience, 1987
- Elevated myc expression and c-myc amplification in spontaneously occurring B lymphoid cell lines.The Journal of Experimental Medicine, 1987
- Calcium Ionophore A23187 Induces Interleukin 2 Reactivity in Human T CellsScandinavian Journal of Immunology, 1985
- Early steps of lymphocyte activation bypassed by synergy between calcium ionophores and phorbol esterNature, 1985
- Modulation of Natural Killer Cell Activity in the Rheumatoid Joint and Peripheral BloodScandinavian Journal of Immunology, 1984
- Induction of cytolytic activity by anti-T3 monoclonal antibody. Activation of alloimmune memory cells and natural killer cells from normal and immunodeficient individuals.JCI Insight, 1984
- Interleukin 2 deficiencies in rheumatoid arthritis and systemic lupus erythematosusClinical Immunology and Immunopathology, 1984
- Evidence That the Malignant Lymphoma of Sjögren's Syndrome Is a Monoclonal B-Cell NeoplasmNew England Journal of Medicine, 1978